Literature DB >> 19631928

Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program.

Christopher V Almario1, Neil S Seligman, Kevin C Dysart, Vincenzo Berghella, Jason K Baxter.   

Abstract

OBJECTIVE: Prior studies noted elevated preterm birth (PTB) rates among opiate-addicted women treated with methadone. We sought to determine the risk factors for PTB in this population. STUDY
DESIGN: We performed a retrospective cohort study of opiate-addicted gravid women treated with methadone who delivered a single neonate between 2000 and 2006. Variables evaluated as potential risk factors for PTB less than 37 weeks included medical and infectious comorbidities and "supplements to methadone" (illicit drugs and/or alcohol).
RESULTS: The overall PTB rate was 29.1% (75/258). No medical or infectious comorbidity was predictive of PTB. Among women abusing 0, 1, 2, or 3 or more supplements in addition to methadone, the PTB rate was 24.2% (reference), 25.5% (P = .50), 47.6% (P = .04), and 64.7% (P = .01), respectively.
CONCLUSION: The PTB rate among women on methadone (29.1%) is nearly 3 times the national average (11.1%), and those abusing 2 or more supplements to methadone are at further increased risk for PTB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631928     DOI: 10.1016/j.ajog.2009.05.052

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  20 in total

1.  Pregnancy and drinking among women offenders under community supervision in the United States: 2004-2008.

Authors:  Hung-En Sung
Journal:  J Urban Health       Date:  2012-06       Impact factor: 3.671

2.  Factors associated with buprenorphine versus methadone use in pregnancy.

Authors:  Elizabeth E Krans; Debra Bogen; Gale Richardson; Seo Young Park; Shannon L Dunn; Nancy Day
Journal:  Subst Abus       Date:  2016-02-25       Impact factor: 3.716

3.  Premature delivery and the millennium development goal.

Authors:  Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2012

4.  Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Authors:  Ursula A Pritham; Jonathan A Paul; Marie J Hayes
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-02-29

5.  A pilot study of the nutritional status of opiate-using pregnant women on methadone maintenance therapy.

Authors:  Laura Elizabeth Tomedi; Debra L Bogen; Barbara H Hanusa; Katherine L Wisner; Lisa M Bodnar
Journal:  Subst Use Misuse       Date:  2012-02       Impact factor: 2.164

Review 6.  The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.

Authors:  Jason R Pryor; Faouzi I Maalouf; Elizabeth E Krans; Robert E Schumacher; William O Cooper; Stephen W Patrick
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2017-01-10       Impact factor: 5.747

Review 7.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

Review 8.  Substance Use in the Perinatal Period.

Authors:  Ariadna Forray; Dawn Foster
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

9.  Should pregnant women with substance use disorders be managed differently?

Authors:  Verena Metz; Birgit Köchl; Gabriele Fischer
Journal:  Neuropsychiatry (London)       Date:  2012-01-25

10.  Comparison of Neonatal Abstinence Syndrome Manifestations in Preterm Versus Term Opioid-Exposed Infants.

Authors:  Elizabeth Allocco; Marjorie Melker; Florencia Rojas-Miguez; Caitlin Bradley; Kristen A Hahn; Elisha M Wachman
Journal:  Adv Neonatal Care       Date:  2016-10       Impact factor: 1.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.